atopic dermatitis

News

NICE okays NHS funding for MS and eczema drugs

The UK's NICE endorsed regular NHS funding for big-selling drugs from Roche and Sanofi, changing its mind in guidance for the multiple sclerosis and eczema drugs.

News

Sanofi’s blockbuster-tipped Dupixent set for European launch...

Sanofi’s new atopic dermatitis treatment Dupixent has gained EU approval, setting it up for a launch across key European markets.

News

Sanofi’s dermatitis drug dupilumab fast-tracked by FDA

Drug could earn $2.8 billion if approved in AD and asthma

NICE okays NHS funding for MS and eczema drugs

Sanofi’s blockbuster-tipped Dupixent set for European launch...

Sanofi’s dermatitis drug dupilumab fast-tracked by FDA

Alzheimer's patients 'not changing brain health behaviours'

Discover a new era of healthcare panel engagement: Grounded ...

Editor's Picks